Abiopharma

Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer

Zebra Technologies Ranked in Wall Street Journal’s Top 10 Companies for AI Readiness

Iron Mountain Incorporated Announces Debt Offering

Salesforce Signs Definitive Agreement to Acquire Fin

Fiserv Announces Leadership Transition

Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway

Xeriants NexBoard™ Successfully Passes Rigorous NFPA 286 Certification Test in Major Step Toward Commercialization

Chase Freedom® Announces Q3 2026 5% Cash Back Categories: Gas Stations and EV Charging, Public Transit, Select Live Entertainment and United Way

Meeting on 18.6.26 – removal of items 7 and 8 from the agenda of the meeting, for the purpose of exhausting discussions with the staff of the Israel Securities Authority and with institutional bodies.

Alto Neuroscience, Inc. - Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia